Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Excited state kinetics of an air-stable cyclometalated iron(II) complex.

Steube J, Burkhardt L, Päpcke A, Moll J, Zimmer P, Schoch R, Wölper C, Heinze K, Lochbrunner S, Bauer M.

Chemistry. 2019 Jun 1. doi: 10.1002/chem.201902488. [Epub ahead of print]

PMID:
31152678
2.

Gold(II) Porphyrins in Photoinduced Electron Transfer Reactions.

Preiß S, Päpcke A, Burkhardt L, Großmann L, Lochbrunner S, Bauer M, Opatz T, Heinze K.

Chemistry. 2019 Apr 23;25(23):5940-5949. doi: 10.1002/chem.201900050. Epub 2019 Mar 29.

PMID:
30786079
3.

The Bonding Situation in the Dinuclear Tetra-Hydrido Complex [{5CpFe}2(μ-H)4] Revisited by Hard X-Ray Spectroscopy.

Burkhardt L, Mueller C, Groß OA, Sun Y, Sitzmann H, Bauer M.

Inorg Chem. 2019 May 20;58(10):6609-6618. doi: 10.1021/acs.inorgchem.8b03032. Epub 2018 Dec 31.

PMID:
30596494
4.

Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis.

Lamprecht P, Fischer N, Huang J, Burkhardt L, Lütgehetmann M, Arndt F, Rolfs I, Kerstein A, Iking-Konert C, Laudien M.

J Autoimmun. 2019 Feb;97:29-39. doi: 10.1016/j.jaut.2018.10.005. Epub 2018 Nov 9.

5.

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population.

Wagner DL, Amini L, Wendering DJ, Burkhardt LM, Akyüz L, Reinke P, Volk HD, Schmueck-Henneresse M.

Nat Med. 2019 Feb;25(2):242-248. doi: 10.1038/s41591-018-0204-6. Epub 2018 Oct 29.

PMID:
30374197
6.

Hydrothermal chimneys host habitat-specific microbial communities: analogues for studying the possible impact of mining seafloor massive sulfide deposits.

Han Y, Gonnella G, Adam N, Schippers A, Burkhardt L, Kurtz S, Schwarz-Schampera U, Franke H, Perner M.

Sci Rep. 2018 Jul 10;8(1):10386. doi: 10.1038/s41598-018-28613-5.

7.

T-Cell Receptor Diversity and the Control of T-Cell Homeostasis Mark Ebola Virus Disease Survival in Humans.

Speranza E, Ruibal P, Port JR, Feng F, Burkhardt L, Grundhoff A, Günther S, Oestereich L, Hiscox JA, Connor JH, Muñoz-Fontela C.

J Infect Dis. 2018 Nov 22;218(suppl_5):S508-S518. doi: 10.1093/infdis/jiy352.

PMID:
29986035
8.

The Connection between NHC Ligand Count and Photophysical Properties in Fe(II) Photosensitizers: An Experimental Study.

Zimmer P, Burkhardt L, Friedrich A, Steube J, Neuba A, Schepper R, Müller P, Flörke U, Huber M, Lochbrunner S, Bauer M.

Inorg Chem. 2018 Jan 2;57(1):360-373. doi: 10.1021/acs.inorgchem.7b02624. Epub 2017 Dec 13.

PMID:
29236487
9.

Insights into Microalga and Bacteria Interactions of Selected Phycosphere Biofilms Using Metagenomic, Transcriptomic, and Proteomic Approaches.

Krohn-Molt I, Alawi M, Förstner KU, Wiegandt A, Burkhardt L, Indenbirken D, Thieß M, Grundhoff A, Kehr J, Tholey A, Streit WR.

Front Microbiol. 2017 Oct 10;8:1941. doi: 10.3389/fmicb.2017.01941. eCollection 2017.

10.

Detection and Characterization of Hydride Ligands in Iron Complexes by High-Resolution Hard X-ray Spectroscopy and Implications for Catalytic Processes.

Burkhardt L, Holzwarth M, Plietker B, Bauer M.

Inorg Chem. 2017 Nov 6;56(21):13300-13310. doi: 10.1021/acs.inorgchem.7b02063.

PMID:
29058447
11.

Comparison of the shaping ability of RaCe, FlexMaster, and ProFile nickel-titanium instruments in severely curved root canals.

Burkhardt L, Weidmann F, Rüttermann S, Gerhardt-Szep S.

J Clin Exp Dent. 2016 Dec 1;8(5):e523-e528. eCollection 2016 Dec.

12.

Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin.

Burkhardt L, Lobitz S, Koustenis E, Rueckriegel SM, Hernáiz Driever P.

Ann Hematol. 2017 Feb;96(2):199-213. doi: 10.1007/s00277-016-2861-1. Epub 2016 Oct 29.

PMID:
27796476
13.

FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.

von Loga K, Kohlhaussen J, Burkhardt L, Simon R, Steurer S, Burdak-Rothkamm S, Jacobsen F, Sauter G, Krech T.

PLoS One. 2015 Nov 10;10(11):e0141867. doi: 10.1371/journal.pone.0141867. eCollection 2015.

14.

Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer.

Krohn A, Freudenthaler F, Harasimowicz S, Kluth M, Fuchs S, Burkhardt L, Stahl P, C Tsourlakis M, Bauer M, Tennstedt P, Graefen M, Steurer S, Sirma H, Sauter G, Schlomm T, Simon R, Minner S.

Mod Pathol. 2014 Dec;27(12):1612-20. doi: 10.1038/modpathol.2014.70. Epub 2014 Apr 25.

15.

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer.

Kluth M, Harasimowicz S, Burkhardt L, Grupp K, Krohn A, Prien K, Gjoni J, Haß T, Galal R, Graefen M, Haese A, Simon R, Hühne-Simon J, Koop C, Korbel J, Weischenfeld J, Huland H, Sauter G, Quaas A, Wilczak W, Tsourlakis MC, Minner S, Schlomm T.

Int J Cancer. 2014 Sep 15;135(6):1369-80. doi: 10.1002/ijc.28784. Epub 2014 Apr 26.

16.

Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR.

Tennstedt P, Bölch C, Strobel G, Minner S, Burkhardt L, Grob T, Masser S, Sauter G, Schlomm T, Simon R.

Int J Oncol. 2014 Feb;44(2):609-15. doi: 10.3892/ijo.2013.2200. Epub 2013 Nov 29.

PMID:
24317684
17.

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy.

Grupp K, Habermann M, Sirma H, Simon R, Steurer S, Hube-Magg C, Prien K, Burkhardt L, Jedrzejewska K, Salomon G, Heinzer H, Wilczak W, Kluth M, Izbicki JR, Sauter G, Minner S, Schlomm T, Tsourlakis MC.

Mod Pathol. 2014 Jan;27(1):96-106. doi: 10.1038/modpathol.2013.127. Epub 2013 Jul 26.

18.

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.

Krohn A, Seidel A, Burkhardt L, Bachmann F, Mader M, Grupp K, Eichenauer T, Becker A, Adam M, Graefen M, Huland H, Kurtz S, Steurer S, Tsourlakis MC, Minner S, Michl U, Schlomm T, Sauter G, Simon R, Sirma H.

J Pathol. 2013 Sep;231(1):130-41. doi: 10.1002/path.4223.

PMID:
23794398
19.

Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

Stumm L, Burkhardt L, Steurer S, Simon R, Adam M, Becker A, Sauter G, Minner S, Schlomm T, Sirma H, Michl U.

J Clin Pathol. 2013 Jul;66(7):563-8. doi: 10.1136/jclinpath-2012-201335. Epub 2013 Apr 4.

PMID:
23559350
20.

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

Burkhardt L, Fuchs S, Krohn A, Masser S, Mader M, Kluth M, Bachmann F, Huland H, Steuber T, Graefen M, Schlomm T, Minner S, Sauter G, Sirma H, Simon R.

Cancer Res. 2013 May 1;73(9):2795-805. doi: 10.1158/0008-5472.CAN-12-1342. Epub 2013 Mar 14.

21.

Laparoscopic appendectomy for perforated appendicitis in children has complication rates comparable with those of open appendectomy.

Vahdad MR, Troebs RB, Nissen M, Burkhardt LB, Hardwig S, Cernaianu G.

J Pediatr Surg. 2013 Mar;48(3):555-61. doi: 10.1016/j.jpedsurg.2012.07.066.

PMID:
23480912
22.

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, Minner S, Wuttig D, Warnatz HJ, Stehr H, Rausch T, Jäger N, Gu L, Bogatyrova O, Stütz AM, Claus R, Eils J, Eils R, Gerhäuser C, Huang PH, Hutter B, Kabbe R, Lawerenz C, Radomski S, Bartholomae CC, Fälth M, Gade S, Schmidt M, Amschler N, Haß T, Galal R, Gjoni J, Kuner R, Baer C, Masser S, von Kalle C, Zichner T, Benes V, Raeder B, Mader M, Amstislavskiy V, Avci M, Lehrach H, Parkhomchuk D, Sultan M, Burkhardt L, Graefen M, Huland H, Kluth M, Krohn A, Sirma H, Stumm L, Steurer S, Grupp K, Sültmann H, Sauter G, Plass C, Brors B, Yaspo ML, Korbel JO, Schlomm T.

Cancer Cell. 2013 Feb 11;23(2):159-70. doi: 10.1016/j.ccr.2013.01.002.

23.

Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

Müller J, Ehlers A, Burkhardt L, Sirma H, Steuber T, Graefen M, Sauter G, Minner S, Simon R, Schlomm T, Michl U.

Int J Cancer. 2013 Mar 15;132(6):1333-40. doi: 10.1002/ijc.27768. Epub 2012 Aug 30.

24.

Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.

Krohn A, Diedler T, Burkhardt L, Mayer PS, De Silva C, Meyer-Kornblum M, Kötschau D, Tennstedt P, Huang J, Gerhäuser C, Mader M, Kurtz S, Sirma H, Saad F, Steuber T, Graefen M, Plass C, Sauter G, Simon R, Minner S, Schlomm T.

Am J Pathol. 2012 Aug;181(2):401-12. doi: 10.1016/j.ajpath.2012.04.026. Epub 2012 Jun 13.

PMID:
22705054
25.

New tool for return-to-work expectations.

Burkhardt L.

Prof Case Manag. 2011 May-Jun;16(3):156-7. doi: 10.1097/NCM.0b013e318212fc02. No abstract available.

PMID:
21475061
26.

Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.

Lebeau A, Turzynski A, Braun S, Behrhof W, Fleige B, Schmitt WD, Grob TJ, Burkhardt L, Hölzel D, Jackisch C, Thomssen C, Müller V, Untch M.

J Clin Oncol. 2010 Jul 10;28(20):3264-70. doi: 10.1200/JCO.2009.25.9366. Epub 2010 May 24.

PMID:
20498397
27.

Gene amplification in ductal carcinoma in situ of the breast.

Burkhardt L, Grob TJ, Hermann I, Burandt E, Choschzick M, Jänicke F, Müller V, Bokemeyer C, Simon R, Sauter G, Wilczak W, Lebeau A.

Breast Cancer Res Treat. 2010 Oct;123(3):757-65. doi: 10.1007/s10549-009-0675-8. Epub 2009 Dec 22.

PMID:
20033484
28.

Consecutive autopsies on an internal medicine service.

Ferguson RP, Burkhardt L, Hennawi G, Puthumana L.

South Med J. 2004 Apr;97(4):335-7.

PMID:
15108824
29.
30.

[Bilateral shape similarity of human ears -- a contribution on the symmetry problem].

Burkhardt L.

Anthropol Anz. 1974 May;34(2):102-11. German. No abstract available.

PMID:
4466447
31.

[Senile metamorphosis of the cranium, its normal and pathological variations, metabolic craniopathy].

Burkhardt L.

Cah Coll Med Hop Paris. 1968 Apr;9(4):321-9. French. No abstract available.

PMID:
5759319
32.

[Metabolic craniopathy. Metamorphosis of the skull in old age with normal pathological variants].

Burkhardt L.

Munch Med Wochenschr. 1968 Mar 29;110(13):780-7. German. No abstract available.

PMID:
5755521
33.

[The question of cyanotic hyperostosis of the skull].

Burkhardt L.

Verh Dtsch Ges Pathol. 1968;52:338-41. German. No abstract available.

PMID:
4182255
34.

[Eberhard von Praun (7-6-1890-10-18-1966)].

Burkhardt L.

Verh Dtsch Ges Pathol. 1967;51:444-5. German. No abstract available.

PMID:
4175856
35.

[On bone alteration of the base of the human skull from histological autopsy findings. (Sella area and clivus in the region of median plane)].

Burkhardt L, Goldstein R, Massinger H.

Virchows Arch Pathol Anat Physiol Klin Med. 1966 Oct 10;341(3):177-82. German. No abstract available.

PMID:
4867341
36.

["The imminent breakthrough in the theory of inflammation"].

BURKHARDT L, BUSSE-GRAWITZ P.

Med Klin. 1961 Jul 7;56:1182-3. German. No abstract available.

PMID:
13689091
37.

[On information of pleural "endothelioma"].

BURKHARDT L.

Verh Dtsch Ges Pathol. 1961;45:240-2. German. No abstract available.

PMID:
13874893
38.

[On relations between bronchial carcinoma and atherosclerosis].

BURKHARDT L.

Med Klin. 1959 Sep 4;54:1613-4. German. No abstract available.

PMID:
13806151
39.

[Morphological test on the characterization of endocrine regulation types in the course of human tuberculosis and its forms].

BURKHARDT L.

Z Mensch Vererb Konstitutionsl. 1956;33(4):301-5. German. No abstract available.

PMID:
13338489
40.

[Kaposi's sarcoma with metastases to the brain].

SCHIRREN CG, BURKHARDT L.

Arch Klin Exp Dermatol. 1955;201(2):99-105. German. No abstract available.

PMID:
13259616
41.

[Skeleton structural changes, especially roof of the cranium and clavicle in adult and their relations to pituitary in accordance with the specific weight and histological findings].

HARTL F, BURKHARDT L.

Virchows Arch Pathol Anat Physiol Klin Med. 1952;322(5):503-28. Undetermined Language. No abstract available.

PMID:
13049752
42.

[Constitutional tuberculous diathesis and morphologic differentiation].

BURKHARDT L.

Munch Med Wochenschr. 1951 Apr 13;93(15):773-7; concl. Undetermined Language. No abstract available.

PMID:
14833358
43.

[Constitutional tuberculous diathesis and morphologic differentiation].

BURKHARDT L.

Munch Med Wochenschr. 1951 Apr 6;93(14):717-23; contd. Undetermined Language. No abstract available.

PMID:
14833346
44.

Lipomatöse Pankreasatrophie bei Bronchiektasien.

BURKHARDT L.

Schweiz Z Pathol Bakteriol. 1949;12(3):203-10. Undetermined Language. No abstract available.

PMID:
18144176
45.

Die Individualität der Norm; zum Begriff der Norm in der Pathologie nebst Bemerkungen über die Variabilität als Grenzgebiet der Krankheitslehre.

BURKHARDT L.

Dtsch Med Wochenschr. 1948 Aug 13;73(29-32):339. Undetermined Language. No abstract available.

PMID:
18883094
46.

Reststickstoffwert und anatomischer Nierenbefund; postmortale Untersuchungen.

HEBOLD G, BURKHARDT L.

Virchows Arch Pathol Anat Physiol Klin Med. 1948;315(5-6):548-56. Undetermined Language. No abstract available.

PMID:
18889330
47.

Zur praktischen Bedeutung der Haut- und Wunddiphtherie.

BURKHARDT L.

Dtsch Med Wochenschr. 1947 Jun 20;72(23-24):324. Undetermined Language. No abstract available.

PMID:
20268562
48.

Messungen der Substanzdichte am menschlichen Gehirn mittels des spezifischen Gewichts; ein Beitrag zur Diagnostik der Hirnschwellung.

BURKHARDT L.

Virchows Arch Pathol Anat Physiol Klin Med. 1947;314(2):260-76. Undetermined Language. No abstract available.

PMID:
20258311
49.

Beitrag zur Entwicklungsmechanik der Hilfsorgane des Auges : Nach Untersuchungen an Anuren.

Burkhardt L.

Wilhelm Roux Arch Entwickl Mech Org. 1930 Dec;121(4):533-544. doi: 10.1007/BF00583340. German. No abstract available.

PMID:
28353802

Supplemental Content

Loading ...
Support Center